GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Curaleaf Holdings CURA.TO · CAD

Health Care · Toronto Stock Exchange · 🇨🇦 Canada

Compare

12.68

-4.16%

Close of 9 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2024

Revenue

$1.34bn

FY2015FY2024

Net income

−$215.4m

FY2015FY2024

Free cash flow

$64.4m

FY2015FY2024

Shareholders' equity

$861.2m

FY2015FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Revenue$1.34bn$1.35bn$1.28bn$1.20bn$626.6m$221.0m$77.1m———
Operating income$20.2m$42.9m$65.0m$58.6m−$152.2m−$125.5m−$45.2m−$96,000−$118,300−$180,000
Net income−$215.4m−$281.2m−$370.1m−$205.9m−$57.2m−$67.2m−$56.5m−$96,000−$118,300−$170,000
Diluted earnings per share-0.28-0.38-0.52-0.29-0.10-0.15-0.14-0.01-0.01-0.02

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Total assets$2.95bn$3.10bn$3.41bn$3.26bn$2.37bn$736.9m$569.8m$31,000$47,700$157,000
Cash and short-term investments$107.2m$91.8m$163.2m$299.3m$73.5m$42.3m$266.6m$900$22,200$130,000
Total liabilities$2.09bn$2.05bn$2.13bn$1.51bn$984.1m$328.2m$129.1m$89,000$11,500$9,000
Debt$939.2m$971.8m$1.02bn$753.6m$577.7m$198.1m$84.3m———
Shareholders' equity$861.2m$1.05bn$1.28bn$1.76bn$1.38bn$408.8m$440.8m−$57,900$36,200$148,100
Shares outstanding741m724m711m699m557m463m396m12m11m8m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash from operations$162.6m$75.3m$46.4m−$58.3m$4.3m−$38.3m−$33.1m−$21,400−$107,000−$168,000
Capital spending−$98.2m−$70.3m−$134.6m−$172.0m−$126.3m−$82.1m−$45.9m—−$600−$9,500
Free cash flow$64.4m$5.0m−$88.2m−$230.2m−$122.0m−$120.4m−$79.0m−$21,400−$107,600−$177,500

Latest quarters

By quarter end

Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023
Revenue$320.2m$314.5m$310.0m$331.1m$330.5m$681.2m$338.9m$345.3m
Operating income$4.0m$3.3m$7.8m−$9.3m$9.2m$20.2m$12.7m$14.0m
Net income−$57.0m−$53.2m−$61.1m−$77.6m−$40.7m−$97.2m−$48.3m−$63.2m
Diluted earnings per share-0.07-0.07-0.07-0.10-0.06-0.13-0.07-0.08
Total assets$2.88bn$2.92bn$2.95bn$2.95bn$3.07bn$3.08bn$3.08bn$3.10bn
Cash and short-term investments$107.5m$102.3m$121.9m$107.2m$90.0m$89.4m$105.0m$91.8m
Debt$851.5m$868.0m$878.2m$819.3m$819.0m$820.5m$840.2m$917.1m
Shareholders' equity$814.8m$871.3m$814.0m$861.2m$958.9m$992.8m$1.02bn$1.05bn

Financial ratios

Data as of 31 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2016
Operating margin2.0%-1.3%3.2%4.9%4.8%11.6%—
Net margin-18.2%-16.0%-20.9%-28.2%-9.0%-9.8%—
Return on equity-31.1%-25.0%-26.8%-29.5%-7.1%-4.5%—
Return on assets-8.3%-7.3%-9.1%-11.0%-3.5%-2.6%—
Free cash flow yield6.8%8.9%5.1%6.6%5.0%5.4%—
Revenue growth-3.9%-0.3%0.8%10.5%93.0%183.5%—
Earnings growth9.1%-23.4%-25.4%245.4%77.9%-12.2%—
Current ratio1.52x1.11x0.85x1.33x2.30x1.90x—
Debt to equity0.77x0.69x0.58x0.51x0.31x0.02x—
Equity ratio26.6%29.2%33.9%37.5%49.8%57.7%—
Interest coverage0.25x-0.17x0.43x0.73x0.75x1.05x—
R&D as a share of sales0.1%0.1%0.1%———0.7%
Buybacks as a share of market value-3.9%-1.2%-2.5%-1.2%-7.1%-42.3%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue3.9%43.5%—
Operating income-29.9%——
Net income1.5%26.2%130.9%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin2.3%3.6%-1.5%—
Net margin-18.5%-20.8%-19.9%—

Valuation history

At each fiscal year end

FY2024FY2023FY2022FY2021
Price to earnings-5.6-10.4-8.2-28.0
Price to sales0.92.22.44.8

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 1-to-0.0384 reverse split · 29 Oct 2018
  • 10-to-1 reverse split · 15 Mar 2018

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.